Ausgabe 1/2010
Inhalt (29 Artikel)
Axillary nodal metastases from carcinoma of unknown primary (CUPAx): a systematic review of published evidence
George Pentheroudakis, George Lazaridis, Nicholas Pavlidis
Prognosis of BRCA-associated breast cancer: a summary of evidence
L. Bordeleau, S. Panchal, P. Goodwin
Emergence of nonanthracycline regimens in the adjuvant treatment of breast cancer
Sumanta K. Pal, Barrett H. Childs, Mark Pegram
Impact of CYP2D6 polymorphisms in tamoxifen adjuvant breast cancer treatment
T. Ramón y Cajal, A. Altés, L. Paré, E. del Rio, C. Alonso, A. Barnadas, M. Baiget
Expression of Gli1 correlates with the transition of breast cancer cells to estrogen-independent growth
Jieying Zhao, Guangchun Chen, Dongmei Cao, Yidong Li, Fei Diao, Haoyu Cai, Yiduo Jin, Jian Lu
Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patients
Shuzhen Liu, Stephen K. Chia, Erika Mehl, Samuel Leung, Ashish Rajput, Maggie C. U. Cheang, Torsten O. Nielsen
Regulation of αB-crystallin gene expression by the transcription factor Ets1 in breast cancer
Joshua D. Bosman, Fruma Yehiely, Joseph R. Evans, Vincent L. Cryns
Growth factor-induced resistance to tamoxifen is associated with a mutation of estrogen receptor α and its phosphorylation at serine 305
Cinzia Giordano, Yukun Cui, Ines Barone, Sebastiano Ando, Michael A. Mancini, Valeria Berno, Suzanne A. W. Fuqua
CASP8 D302H polymorphism delays the age of onset of breast cancer in BRCA1 and BRCA2 carriers
Sarai Palanca Suela, Eva Esteban Cardeñosa, Eva Barragán González, Inmaculada de Juan Jiménez, Isabel Chirivella González, Ángel Segura Huerta, Carmen Guillén Ponce, Eduardo Martínez de Dueñas, Joaquín Montalar Salcedo, Victoria Castel Sánchez, Pascual Bolufer Gilabert
FEC versus sequential docetaxel followed by epirubicin/cyclophosphamide as adjuvant chemotherapy in women with axillary node-positive early breast cancer: a randomized study of the Hellenic Oncology Research Group (HORG)
Aristides Polyzos, Nikolaos Malamos, Ioannis Boukovinas, Adamos Adamou, Nikolaos Ziras, Kostas Kalbakis, Stylianos Kakolyris, Kostas Syrigos, Pavlos Papakotoulas, Charalambos Kouroussis, Nikolaos Karvounis, Lambros Vamvakas, Charalambos Christophyllakis, Athanasios Athanasiadis, Ioannis Varthalitis, Vassilis Georgoulias, Dimitris Mavroudis
Pain perception and detailed visual pain mapping in breast cancer survivors
Sebastian M. Jud, Peter A. Fasching, Christian Maihöfner, Katharina Heusinger, Christian R. Loehberg, Reinhard Hatko, Claudia Rauh, Hiba Bani, Michael P. Lux, Matthias W. Beckmann, Mayada R. Bani
Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer
Qamar J. Khan, Pavan S. Reddy, Bruce F. Kimler, Priyanka Sharma, Susan E. Baxa, Anne P. O’Dea, Jennifer R. Klemp, Carol J. Fabian
Concordance of clinical and molecular breast cancer subtyping in the context of preoperative chemotherapy response
Jorma J. de Ronde, Juliane Hannemann, Hans Halfwerk, Lennart Mulder, Marieke E. Straver, Marie-Jeanne T. F. D. Vrancken Peeters, Jelle Wesseling, Marc van de Vijver, Lodewyk F. A. Wessels, Sjoerd Rodenhuis
Randomized phase III trial of trastuzumab monotherapy followed by trastuzumab plus docetaxel versus trastuzumab plus docetaxel as first-line therapy in patients with HER2-positive metastatic breast cancer: the JO17360 Trial Group
Kenichi Inoue, Kazuhiko Nakagami, Mitsuhiro Mizutani, Yasuo Hozumi, Yasuhiro Fujiwara, Norikazu Masuda, Fumine Tsukamoto, Mitsue Saito, Shigeto Miura, Kenji Eguchi, Tetsu Shinkai, Masashi Ando, Toru Watanabe, Noriyuki Masuda, Yasuo Ohashi, Muneaki Sano, Shinzaburo Noguchi
Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer
Elisabeth R. Garwood, Anjali S. Kumar, Frederick L. Baehner, Dan H. Moore, Alfred Au, Nola Hylton, Chris I. Flowers, Judy Garber, Beth-Ann Lesnikoski, E. Shelley Hwang, Olofunmilao Olopade, Elisa Rush Port, Michael Campbell, Laura J. Esserman
The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial
Evandro de Azambuja, Worta McCaskill-Stevens, Prudence Francis, Emmanuel Quinaux, John P. A. Crown, Malou Vicente, Rosa Giuliani, Bo Nordenskjöld, Jorge Gutiérez, Michael Andersson, Mireia Margeli Vila, Raimund Jakesz, Jan Demol, Joanna Dewar, Armando Santoro, Ana Lluch, Steven Olsen, Richard D. Gelber, Angelo Di Leo, Martine Piccart-Gebhart
A randomized trial exploring the biomarker effects of neoadjuvant sequential treatment with exemestane and anastrozole in post-menopausal women with hormone receptor-positive breast cancer
O. C. Freedman, E. Amir, W. Hanna, H. Kahn, F. O’Malley, G. Dranitsaris, D. E. C. Cole, S. Verma, E. Folkerd, M. Dowsett, M. Clemons
Does pre-operative breast magnetic resonance imaging in addition to mammography and breast ultrasonography change the operative management of breast carcinoma?
Hye In Lim, Jae Hyuck Choi, Jung-Hyun Yang, Boo-Kyung Han, Jeong Eon Lee, Se-Kyung Lee, Wan Wook Kim, Sangmin Kim, Jee Soo Kim, Jung-Han Kim, Jun-Ho Choe, Eun Yoon Cho, Seok Seon Kang, Jung Hee Shin, Eun Young Ko, Sang Wook Kim, Seok Jin Nam
Concomitant docetaxel plus gemcitabine versus sequential docetaxel followed by gemcitabine in anthracycline-pretreated metastatic or locally recurrent inoperable breast cancer patients: a prospective multicentre trial of the Central European Cooperative Oncology Group (CECOG)
Antoaneta Tomova, Rupert Bartsch, Thomas Brodowicz, Valentina Tzekova, Constanta Timcheva, Christoph Wiltschke, Dany Abi Gerges, Jan Pawlega, Stanislav Spanik, Moshe Inbar, Christoph C. Zielinski
Breast cancer-related preferences among women with and without BRCA mutations
Victor R. Grann, Priya Patel, Anubha Bharthuar, Judith S. Jacobson, Ellen Warner, Kristin Anderson, Eiran Warner, Wei-Yann Tsai, Kimberly A. Hill, Alfred I. Neugut, Dawn Hershman
Etiologic factors for male breast cancer in the U.S. Veterans Affairs medical care system database
Louise A. Brinton, J. Daniel Carreon, Gretchen L. Gierach, Katherine A. McGlynn, Gloria Gridley
BRCA1-associated breast and ovarian cancer risks in Poland: no association with commonly studied polymorphisms
Anna Jakubowska, Jacek Gronwald, Janusz Menkiszak, Bohdan Górski, Tomasz Huzarski, Tomasz Byrski, Aleksandra Tołoczko-Grabarek, Michael Gilbert, Lutz Edler, Marc Zapatka, Roland Eils, Jan Lubiński, Rodney J. Scott, Ute Hamann
The impact of sociodemographic, treatment, and work support on missed work after breast cancer diagnosis
Mahasin S. Mujahid, Nancy K. Janz, Sarah T. Hawley, Jennifer J. Griggs, Ann S. Hamilton, Steven J. Katz
Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers
Roger L. Milne, Ana Osorio, Teresa Ramón y Cajal, Montserrat Baiget, Adriana Lasa, Eduardo Diaz-Rubio, Miguel de la Hoya, Trinidad Caldés, Alex Teulé, Conxi Lázaro, Ignacio Blanco, Judith Balmaña, Gessamí Sánchez-Ollé, Ana Vega, Ana Blanco, Isabel Chirivella, Eva Esteban Cardeñosa, Mercedes Durán, Eladio Velasco, Eduardo Martínez de Dueñas, María-Isabel Tejada, María-Dolores Miramar, María-Teresa Calvo, Carmen Guillén-Ponce, Raquel Salazar, Carlos San Román, Miguel Urioste, Javier Benítez
Identification of a novel mutations BRCA1*c.80 + 3del4 and BRCA2*c.6589delA in Slovak HBOC families
Michal Konecny, Miriam Vizvaryova, Katarina Zavodna, Regina Behulova, Maria Gerykova Bujalkova, Tomas Krivulcik, Frantisek Cisarik, Juraj Kausitz, Eva Weismanova
Identification and functional analysis of novel BRCA1 transcripts, including mouse Brca1-Iris and human pseudo-BRCA1
Christopher A. Pettigrew, Juliet D. French, Jodi M. Saunus, Stacey L. Edwards, Aisha V. Sauer, Chanel E. Smart, Therese Lundström, Christiane Wiesner, Amanda B. Spurdle, Joseph A. Rothnagel, Melissa A. Brown
Controversial BRCA1 allelotypes in commonly used breast cancer cell lines
Sivasundaram Karnan, Morassa Mohseni, Yuko Konishi, Akina Tamaki, Yoshitaka Hosokawa, Ben H. Park, Hiroyuki Konishi
Bisphosphonate-related osteonecrosis of the jaw in randomized clinical trials
Athanassios Kyrgidis